Table 3.
Health self-efficacy |
Emotional well-being |
Functional well-being |
|
---|---|---|---|
Direct and total effects: Coefficients | |||
IV on mediator | −.54*** | −.48** | −.48† |
Mediator on DV | −.24* | −.32* | −.39*** |
Total effect of IV on DV | 31† | .43* | .58** |
Direct effect of IV on DV | .18 | .27 | .39* |
Formal tests of the indirect effect | |||
Sobel: z value | 1.90* | 1.85* | 2.23* |
Bootstrapping: 95% CI | .015 – .353 | .031 – .357 | .059 – .407 |
Note. N = 106.
p < .06,
p < .05,
p < .01,
p < .001.
IV refers to disclosure of insights; mediator is breast cancer concerns at follow-up; DV refers to each of the health outcomes (health self-efficacy, emotional well-being, and functional well-being) assessed at follow-up. Individual background characteristics and baseline variable were also entered in the analyses as covariates. The significance of Sobel z value was tested with one-tailed p values.